C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
73.76%
↑ 377% above average
Average (26q)
15.47%
Historical baseline
Range
High:240.73%
Low:-244.09%
Volatility
3134.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 73.76% |
| Q2 2025 | -10.71% |
| Q1 2025 | 112.20% |
| Q4 2024 | -74.36% |
| Q3 2024 | 33.58% |
| Q2 2024 | 227.77% |
| Q1 2024 | 93.57% |
| Q4 2023 | -82.70% |
| Q3 2023 | 240.73% |
| Q2 2023 | 110.54% |
| Q1 2023 | 9.05% |
| Q4 2022 | -21.34% |
| Q3 2022 | -30.99% |
| Q2 2022 | 5.71% |
| Q1 2022 | -186.56% |
| Q4 2021 | 59.04% |
| Q3 2021 | -17.01% |
| Q2 2021 | -3.09% |
| Q1 2021 | -7.63% |
| Q4 2020 | -244.09% |
| Q3 2020 | -12.65% |
| Q2 2020 | 201.83% |
| Q1 2020 | -21.62% |
| Q4 2019 | -2.95% |
| Q3 2019 | -34.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |